{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:47:53Z","timestamp":1775580473163,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T00:00:00Z","timestamp":1691452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jdcr.2023.07.038","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T16:49:14Z","timestamp":1691858954000},"page":"34-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Pityriasis lichenoides chronica in a patient on tafasitamab and lenalidomide therapy for diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"40","author":[{"given":"Katie","family":"Roster","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Kann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Zufall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Farabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marian","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijan","family":"Safai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2023.07.038_bib1","series-title":"Fitzpatrick\u2019s Dermatology","article-title":"Parapsoriasis and Pityriasis lichenoides","author":"Schieke","year":"2019"},{"issue":"4","key":"10.1016\/j.jdcr.2023.07.038_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaad.2005.07.058","article-title":"Pityriasis lichenoides and its subtypes","volume":"55","author":"Bowers","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.jdcr.2023.07.038_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12288-014-0344-x","article-title":"Pityriasis lichenoids chronica as a paraneoplastic Dermatosis for primary splenic diffuse large B cell lymphoma","volume":"30","author":"Lu","year":"2014","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"11","key":"10.1016\/j.jdcr.2023.07.038_bib4","doi-asserted-by":"crossref","DOI":"10.5070\/D32311037249","article-title":"Pityriasis lichenoides-like drug reaction: A clinical histopathologic study of 10 cases","volume":"23","author":"Magro","year":"2017","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.jdcr.2023.07.038_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000247503","article-title":"Atypical manifestations of pityriasis lichenoides chronica: development into paraneoplasia and non-Hodgkin lymphomas of the skin","volume":"184","author":"Panizzon","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.jdcr.2023.07.038_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211027458","article-title":"The use of tafasitamab in diffuse large B-cell lymphoma","volume":"12","author":"D\u00fcll","year":"2021","journal-title":"Ther Adv Hematol"},{"issue":"7","key":"10.1016\/j.jdcr.2023.07.038_bib7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S1470-2045(20)30225-4","article-title":"Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): A multicentre, prospective, single-arm, phase 2 study","volume":"21","author":"Salles","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623002916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512623002916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:25:19Z","timestamp":1762475119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512623002916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":7,"alternative-id":["S2352512623002916"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.07.038","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pityriasis lichenoides chronica in a patient on tafasitamab and lenalidomide therapy for diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2023.07.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}